DB
Deepak L. Bhatt
Highly rated in
52
conditions

Dr. Deepak L. Bhatt

Brigham And Women's Hospital, Division Of Cardiovascular Medicine
Boston, MA
Highly rated in
52
conditions
Specialties:Cardiology | Interventional Cardiology
Experience:30 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
Highly rated in
52
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Deepak L. Bhatt's experience treating your condition:
About Dr. Deepak L. Bhatt

Deepak Bhatt is a Cardiologist and an Interventional Cardiologist in Boston, Massachusetts. Bhatt has been practicing medicine for over 30 years and is highly rated in 52 conditions, according to our data. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG). He is licensed to treat patients in Massachusetts, Rhode Island, and New York. Bhatt is currently accepting new patients.

His clinical research consists of co-authoring 1728 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Deepak L. Bhatt it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Deepak L. Bhatt accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
75 Francis St, Boston, MA 02115
Background & Education
Graduate Institution
Js Weill Medical College, Cornell University, 1993
Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in RI
Hospital Affiliations
Brigham And Womens Hospital
Kent Hospital
Brigham And Womens Faulkner Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Enrollment Status: Recruiting
Publish Date: June 16, 2022
Evaluation of the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients With Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events With EPA - Intervention Trial)
Enrollment Status: Completed
Publish Date: April 14, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study).
Enrollment Status: Completed
Publish Date: March 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Enrollment Status: Completed
Publish Date: April 26, 2017
Intervention Type: Diagnostic Test, Device
Study Phase: Not Applicable
Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors
Enrollment Status: Terminated
Publish Date: May 20, 2016
Intervention Type: Drug
Study Phase: Phase 3
A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 17, 2014
Intervention Type: Drug
Study Phase: Phase 4
A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention (PCI).
Enrollment Status: Terminated
Publish Date: May 08, 2014
Intervention Type: Drug
Study Phase: Phase 3
A Clinical Trial Comparing Treatment With Cangrelor (in Combination With Usual Care) to Usual Care, in Subjects Who Require Percutaneous Coronary Intervention (PCI).
Enrollment Status: Terminated
Publish Date: May 05, 2014
Intervention Type: Drug
Study Phase: Phase 3
The BEACON Registry: Best Expert Agreement for Care of Occult MI Nationally
Enrollment Status: Terminated
Publish Date: February 22, 2010
Protocol for a Randomized, Placebo-Controlled, Double-Blinded Trial to Study the Effects of Supplementary Omega-3 Fatty Acids on Serum C-Reactive Protein Levels
Enrollment Status: Terminated
Publish Date: December 21, 2007
Intervention Type: Dietary Supplement
Study Phase: Phase 4
View 9 Less Clinical Trials -
1725 Total Publications
Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United States.
Journal: Journal of palliative care
Published: November 14, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
RY
Dr. Robert W. Yeh
Cardiology | Interventional Cardiology
Highly rated in
25
conditions
Cardiology
Interventional Cardiology

Beth Israel Lahey Health

BIDMC - Division Of Cardiology

185 Pilgrim Rd, 
Boston, MA 
 0.2 mi

Robert Yeh is a Cardiologist and an Interventional Cardiologist in Boston, Massachusetts. Yeh has been practicing medicine for over 20 years and is highly rated in 25 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Heart Failure, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG). He is licensed to treat patients in Massachusetts. Yeh is currently accepting new patients.

JP
Dr. Jeffrey J. Popma
Cardiology | Interventional Cardiology
Highly rated in
23
conditions
Cardiology
Interventional Cardiology

Beth Israel Lahey Health

Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

185 Pilgrim Rd # Baker4, 
Boston, MA 
 0.2 mi

Jeffrey Popma is a Cardiologist and an Interventional Cardiologist in Boston, Massachusetts. Popma has been practicing medicine for over 42 years and is highly rated in 23 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Massachusetts. Popma is currently accepting new patients.

PS
Dr. Pinak B. Shah
Cardiology | Interventional Cardiology
Highly rated in
21
conditions
Cardiology
Interventional Cardiology

Brigham Health

Brigham And Womens Physicians Organization Inc

70 Francis St, 
Boston, MA 
 0.1 mi

Pinak Shah is a Cardiologist and an Interventional Cardiologist in Boston, Massachusetts. Shah has been practicing medicine for over 29 years and is highly rated in 21 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Massachusetts. Shah is currently accepting new patients.